Anergis has a total of 69 patents globally, out of which 44 have been granted. Of these 69 patents, more than 30% patents are active. The United States of America is where Anergis has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also Switzerland is the origin country of Anergis.
Anergis was founded in 2001. Anergis produces pharmaceutical drugs. In order to promote desensitization to common allergens, the company develops and evaluates biopharmaceutical allergy vaccines.
Do read about some of the most popular patents of Anergis which have been covered by us in this article and also you can find Anergis patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Anergis patent portfolio.
How many patents does Anergis have?
Anergis has a total of 69 patents globally. These patents belong to 8 unique patent families. Out of 69 patents, 21 patents are active.
How Many Patents did Anergis File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Anergis Applications Filed | Anergis Patents Granted |
| 2021 | – | 1 |
| 2020 | – | 5 |
| 2019 | 2 | – |
| 2018 | – | 3 |
| 2017 | 1 | 6 |
| 2016 | 2 | 5 |
| 2015 | 1 | 4 |
| 2014 | 12 | 4 |
| 2013 | 2 | 3 |
| 2012 | 10 | 1 |
| 2011 | 2 | 2 |
How many Anergis patents are Alive/Dead?
Worldwide Patents
How Many Patents did Anergis File in Different Countries?
Countries in which Anergis Filed Patents
| Country | Patent |
| United States Of America | 12 |
| Europe | 9 |
| Japan | 9 |
| Australia | 7 |
| Canada | 6 |
| Denmark | 3 |
| Germany | 3 |
| Spain | 3 |
| Austria | 2 |
| Poland | 2 |
| Hungary | 1 |
| Turkey | 1 |
| Slovenia | 1 |
| Brazil | 1 |
| China | 1 |
| Croatia | 1 |
| Russia | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centers of Anergis Patents Located?
The Research Centers of Anergis Patents is the United States of America.
10 Best Anergis Patents
US8075897B2 is the most popular patent in the Anergis portfolio. It has received 18 citations so far from companies like Regeneron Pharmaceuticals, Sanofi Biotechnology, Divine Api-Logics.
Below is the list of 10 most cited patents of Anergis:
| Publication Number | Citation Count |
| US8075897B2 | 18 |
| US20150050301A1 | 14 |
| US7923209B2 | 8 |
| CN105307679A | 8 |
| US6780416B1 | 6 |
| US6878376B2 | 5 |
| US9005627B2 | 2 |
| JP05390742B2 | 2 |
| US8343503B2 | 1 |
| US9808503B2 | 1 |
What Percentage of Anergis US Patent Applications Were Granted?
Anergis (Excluding its subsidiaries) has filed 12 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 75 have been granted leading to a grant rate of 75%.
Below are the key stats of Anergis patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Anergis?
| Law Firm | Total Applications | Success Rate |
| Marshall Gerstein & Borun | 9 | 66.67% |
| Ivor R Elrifi | 1 | 100.00% |
| Jeffrey S Sharp | 1 | 100.00% |
| Mintz Levin Boston Office | 1 | 100.00% |
What are Anergis key innovation segments?
What Technologies are Covered by Anergis?
The chart below distributes patents filed by Anergis